688613.SH
奥精医疗
SSE · Healthcare · Medical - Devices · CN
CNY 15.07
−2.46%Year over year
Reported trailing growth
- Revenue
- +14.3%
- EBITDA
- —
- EBIT
- +199.8%
- EPS
- +178.4%
- Free cash flow
- +87.9%
- Operating cash flow
- +172.0%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- -3.0%
- EBITDA
- -28.3%
- EBIT
- -50.1%
- Net income
- -47.4%
- EPS
- -48.0%
- Free cash flow
- -42.9%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Mar 1, 2026